ANI Pharmaceuticals, Inc (ANIP)

Etorro trading 970x250

About ANI Pharmaceuticals, Inc

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota. Address: 210 Main Street West, Baudette, MN, United States, 56623

ANI Pharmaceuticals, Inc News and around…

Latest news about ANI Pharmaceuticals, Inc (ANIP) common stock and company :

Analysts Expect 19% Upside For IJR
10 Jan, 2022 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Core S&P Small-Cap ETF (IJR), we found that the implied analyst target price for the ETF based upon its underlying holdings is $134.22 per unit.

From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances
05 Jan, 2022 FinancialContent

Photo by David Matos on Unsplash The following post was written and/or published as a collaboration between Benzinga’s ...

ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference
03 Jan, 2022 FinancialContent

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present virtually at the H.C. Wainwright Bioconnect Conference as follows:

Bargain Hunters Take Note: Insider Cluster-Buying At ANIP
23 Dec, 2021 FinancialContent

A particularly strong insider buying signal is what we call a "cluster-buy" where three or more different insiders make open market purchases within a short period of one another. At ANI Pharmaceuticals Inc (ANIP), 3 different insiders purchased 6,572 shares at an average price of $41.85/share, for a total of $275,063, with the most recent purchase on December 20, 2021.

The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail
21 Dec, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CytomX Mid-Phase Study Of ...

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP
21 Dec, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that the Company received U.S. Food and Drug Administration (“FDA”) approval for the Abbreviated New Drug Application for Rifabutin Capsules USP, 150 mg.

Mobile Clinics Featuring Novel Mental Health Treatments Reportedly Coming to Florida and Nevada
20 Dec, 2021 FinancialContent

Photo by Insung Yoon on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house ...

Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tablets, the First and Only FDA-Approved Generic Version of Carbaglu® (carglumic acid)
20 Dec, 2021 Yahoo! Finance

Product is now available exclusively through Anovo specialty pharmacyProduct is stable at room temperature while Carbaglu® requires refrigerationEton Cares patient support program will offer $0 co-pays to commercial insurance patients DEER PARK, Ill., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases and ANI Pharmaceuticals, Inc (Nasdaq: ANIP), a bio-pharmaceutica

7 of the Best Small-Cap Stocks to Buy Before 2022
16 Dec, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With 2021 coming to a close and a new year upon us, it's time to get a head start on some of the best small-cap stocks to buy. The post 7 of the Best Small-Cap Stocks to Buy Before 2022 appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

This Biotech Company Specializing in Brain Disorder Treatments Reports a Stronger Cash Position
13 Dec, 2021 FinancialContent

Photo by Hal Gatewood on Unsplash The following post was written and/or published as a collaboration between Benzinga’s ...

Analysts See 20% Upside For SLY
10 Dec, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— S&P 600 Small Cap ETF (SLY), we found that the implied analyst target price for the ETF based upon its underlying holdings is $117.77 per unit.

ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses
22 Nov, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities.

ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021
22 Nov, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present virtually at the Piper Sandler 33rd Annual Healthcare Conference 2021 as follows:

ANI Pharmaceuticals Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma
11 Nov, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Federal Trade Commission (the FTC) has accepted the proposed consent order in connection with ANI's definitive agreement to acquire Novitium Pharma. The divestitures required by the FTC of development rights to one generic drug and assets with respect to another generic drug are immaterial to the Company’s business.

U.S. FTC approves ANI deal to buy Novitium, with conditions
10 Nov, 2021 Yahoo! Finance

Specialty pharmacy company ANI Pharmaceuticals Inc has won U.S. antitrust approval to buy Novitium Pharma LLC on condition it divest rights or assets related to two generic medicines, the Federal Trade Commission said on Wednesday. The companies, which announced their $210 million deal in March, agreed to sell ANI's development rights to generic sulfamethoxazole-trimethoprim oral suspension, a combination of antibiotics, and assets related to generic dexamethasone, used to treat inflammation and arthritis. ANI already sells the antibiotic and is well-positioned to sell the anti-inflammatory while Novitium is a potential seller of both.

The Math Shows VIOG Can Go To $279
09 Nov, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard S&P Small-Cap 600 Growth ETF (VIOG), we found that the implied analyst target price for the ETF based upon its underlying holdings is $278.96 per unit.

ANI Pharmaceuticals, Inc. Announces Closing of $75 Million Public Offering of Common Stock
08 Nov, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (ANI or the Company) today announced the closing of its previously announced underwritten public offering. A total of 1,500,000 shares of its common stock were sold at a public offering price of $50.00 per share. The gross proceeds of the offering to the Company are $75 million, before deducting the underwriting discounts and commissions and offering expenses. In addition, ANI granted the underwriters a 30-day option to purchase up to an additional 225,000 shares of common stock at the public offering price, less underwriting discounts and commissions.

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
04 Nov, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral ...

ANI Pharmaceuticals, Inc. Announces Pricing of $75 Million Public Offering of Common Stock
04 Nov, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (“ANI” or the "Company") today announced the pricing of an underwritten public offering of 1,500,000 shares of its common stock at a public offering price of $50.00 per share. The gross proceeds of the offering to the Company are expected to be $75 million, before deducting the underwriting discounts and commissions and other offering expenses. In addition, ANI granted the underwriters a 30-day option to purchase up to an additional 225,000 shares of common stock at the public offering price, less underwriting discounts and commissions.

ANI Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
03 Nov, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (“ANI”) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered by ANI. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, ANI intends to grant the underwriters a 30-day option to purchase up to an additional 15% of shares of its common stock offered in the public offering.

Notable Tuesday Option Activity: ANIP, CPRI, AMC
02 Nov, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ANI Pharmaceuticals Inc (ANIP), where a total of 2,766 contracts have traded so far, representing approximately 276,600 underlying shares. That amounts to about 104% of ANIP's average daily trading volume over the past month of 265,955 shares..

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021
02 Nov, 2021 FinancialContent

Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE:OGS) from Neutral to Buy. For the third quarter, ONE Gas ...

Insiders who bought ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) last year must be regretting not buying more as market cap hits US$677m
02 Nov, 2021 Yahoo! Finance

ANI Pharmaceuticals, Inc. ( NASDAQ:ANIP ) insiders who bought shares over the past year were rewarded handsomely last...

64 Biggest Movers From Yesterday
02 Nov, 2021 FinancialContent

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock ...

ANI Pharmaceuticals, inc (ANIP) Q3 2021 Earnings Call Transcript
02 Nov, 2021 FinancialContent

ANIP earnings call for the period ending September 30, 2021.

ANI Pharma's Purified Cortrophin Gel Scores FDA Approval; Q3 Earnings Beat Estimates
01 Nov, 2021 FinancialContent

ANI Pharmaceuticals Inc(NASDAQ: ANIP) hasreported Q3 sales of $52.1 million, down 1.7% Y/Y, better than the consensus of ...

Mid-Afternoon Market Update: loanDepot Surges After Q3 Results; Mirati Therapeutics Shares Slide
01 Nov, 2021 FinancialContent

Toward the end of trading Monday, the Dow traded up 0.12% to 35,863.70 while the NASDAQ rose 0.18% to 15,525.52. The S&P, however, ...

Dow, SPX Fall From Record Intraday Highs
01 Nov, 2021 FinancialContent

Stocks are mixed at midday, with the Dow Jones Industrial Average reversing some of this morning's gains after briefly toppling the 36,000 level for the first time ever.

12 Health Care Stocks Moving In Monday's Intraday Session
01 Nov, 2021 FinancialContent

Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As ...

Here's Why Ani Pharmaceuticals Stock Is Rocketing Higher Today
01 Nov, 2021 FinancialContent

The company reported positive third-quarter earnings, and the FDA granted approval for its generic version of Acthar Gel.

ANI Pharmaceuticals, Inc (ANIP) is a NASDAQ Common Stock listed in , ,

970x250